연구성과로 돌아가기
2022 연구자 정보 (751 / 1074)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Mi-Hyun (Kim, MH) |
Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea Pusan Natl Univ, Dept Internal Med, Sch Med, Busan, South Korea Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea |
|
|
[JCR상위 39.6] Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial [JCR상위 87.3] First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea |
SCIE | 39.6 |
ONCOLOGY;RESPIRATORY SYSTEM ONCOLOGY |
kyc0923@jnu.ac.kr; jangtw22@hanmail.net; |
||
|
Kim, Sang-We (Kim, SW) |
Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea |
|
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study | SCIE | 39.6 | ONCOLOGY | srpark@amc.seoul.kr; | ||
|
Kim, Se Hyun (Kim, SH) |
Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea |
KDN-3343-2024 Kim, Sehyun |
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study | SCIE | 39.6 | ONCOLOGY | srpark@amc.seoul.kr; | ||
|
Kim, Sun Young (Kim, SY) |
Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea |
|
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study | SCIE | 39.6 | ONCOLOGY | srpark@amc.seoul.kr; | ||
|
Kim, Sung-Bae (Kim, SB) |
Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan Coll Med, Asan Med Ctr, Seoul, South Korea |
AAI-3081-2021 JXL-8219-2024 Kim, Sung Kim, Sung-Bae |
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study [JCR상위 0.9] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer |
SCIE | 0.9 |
ONCOLOGY MEDICINE, GENERAL & INTERNAL |
srpark@amc.seoul.kr; modis@mskcc.org; |
||
|
Kim, Young-Chul (Kim, YC) |
교신저자 |
Chonnam Natl Univ, Med Sch, Dept Internal Med, Jeonnam, South Korea Hwasun Hosp, Jeonnam, South Korea Chonnam Natl Univ Med Sch, Hwasun Hosp, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea |
AAK-1840-2021 Kim, Yong-Joo |
|
[JCR상위 39.6] Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial | SCIE | 39.6 | ONCOLOGY;RESPIRATORY SYSTEM | kyc0923@jnu.ac.kr; | |
|
Kim, Yu Jung (Kim, YJ) |
Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea |
|
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study | SCIE | 39.6 | ONCOLOGY | srpark@amc.seoul.kr; | ||
|
Koh, Su-Jin (Koh, SJ) |
Ulsan Univ Hosp, Div Hematol & Oncol, Ulsan, South Korea |
|
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study | SCIE | 39.6 | ONCOLOGY | srpark@amc.seoul.kr; | ||
|
Lee, Dae Ho (Lee, DH) |
Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon 21565, South Korea |
|
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study [JCR상위 5.8] Externalized phosphatidylinositides on apoptotic cells are eat-me signals recognized by CD14 |
SCIE | 5.8 |
ONCOLOGY BIOCHEMISTRY & MOLECULAR BIOLOGY;CELL BIOLOGY |
srpark@amc.seoul.kr; steven.shoelson@joslin.harvard.edu;bcoh@gachon.ac.kr; |
||
|
Lee, Gil Joon (Lee, GJ) |
Kyungpook Natl Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea |
|
|
[JCR상위 39.6] Prevalence and characteristics of vagus nerve variations on neck ultrasonography [JCR상위 46.8] Evaluation of Carotid Space Schwannoma Using Ultrasonography Characteristics and Role in Defining the Nerve of Origin [JCR상위 61.6] Ultrasonography for masses of the pharynx and larynx and assessment of laryngeal squamous cell carcinoma [JCR상위 61.6] Prevalence and characteristics of tonsillar human papillomavirus infection in tumor-free patients undergoing tonsillectomy |
SCIE | 39.6 |
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING ACOUSTICS;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING OTORHINOLARYNGOLOGY |
godlikeu@naver.com; godlikeu@naver.com;blueskyhsj@hanmail.net; |
||
|
Lee, Jae Cheol (Lee, JC) |
Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea |
|
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study | SCIE | 39.6 | ONCOLOGY | srpark@amc.seoul.kr; | ||
|
Lee, Min Ki (Lee, MK) |
Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea Pusan Natl Univ, Dept Internal Med, Sch Med, Busan, South Korea |
HTO-6715-2023 LEE, Ji-Sun Lee |
|
[JCR상위 39.6] Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial [JCR상위 64.4] Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer [JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies [JCR상위 34.5] Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies |
SCIE | 1.9 |
ONCOLOGY;RESPIRATORY SYSTEM ONCOLOGY BIOTECHNOLOGY & APPLIED MICROBIOLOGY;ONCOLOGY |
kyc0923@jnu.ac.kr; ccm@amc.seoul.kr; sanjay.popat@rmh.nhs.uk; |
||
|
Lee, Sung Yong (Lee, SY) |
Korea Univ, Dept Internal Med, Guro Hosp, Seoul, South Korea Korea Univ, Coll Med, Div Pulm Allergy & Crit Care Med, Seoul, South Korea Korea Univ, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med, Guro Hosp, Seoul, South Korea |
ADE-2110-2022 Lee, Joo Yong |
0000-0002-8693-5792 LEE, SUNG YONG |
[JCR상위 39.6] Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial [JCR상위 64.4] Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer [JCR상위 87.3] First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea |
SCIE | 39.6 |
ONCOLOGY;RESPIRATORY SYSTEM ONCOLOGY |
kyc0923@jnu.ac.kr; ccm@amc.seoul.kr; jangtw22@hanmail.net; |
||
|
Min, Young Joo (Min, YJ) |
Ulsan Univ Hosp, Div Hematol & Oncol, Ulsan, South Korea |
|
|
[JCR상위 39.6] The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study | SCIE | 39.6 | ONCOLOGY | srpark@amc.seoul.kr; | ||
|
Oh, Hyung-Joo (Oh, HJ) |
Chonnam Natl Univ, Med Sch, Dept Internal Med, Jeonnam, South Korea Hwasun Hosp, Jeonnam, South Korea |
|
|
[JCR상위 39.6] Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial | SCIE | 39.6 | ONCOLOGY;RESPIRATORY SYSTEM | kyc0923@jnu.ac.kr; |
페이지 이동: